Inversiones La Construcción (ILC) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Oct, 2026Executive summary
Q1 2025 consolidated profit was CLP 39,560m, down 33.2% YoY as global market volatility weakened financial subsidiaries; stronger healthcare operations partly offset the decline.
Consolidated net operating income rose 36.6% to CLP 65,368m, while non-operating results swung to a CLP 20,164m loss from CLP 25,952m income.
2023–2027 priorities include growth in financial businesses, diversification, retail financing, profitability and operational efficiency.
Financial highlights
Profit fell from CLP 59.3bn in Q1 2024 to CLP 39.6bn in Q1 2025; the prior-year period included a CLP 32.37bn extraordinary loss tied to the Isapres Short Law.
Division contributions included AFP Habitat profit of CLP 13.4bn, Banco Internacional profit of CLP 10.0bn, Consalud profit of CLP 6.5bn and RedSalud profit of CLP 4.0bn.
Consolidated assets were CLP 16,723,655m at March 2025, up 1.4% from December 2024; equity attributable to owners rose 1.4% to CLP 1,147,732m.
Outlook and guidance
Banco Internacional plans to expand corporate and retail financing, diversify products and funding, grow its client base and develop digital products with digital onboarding.
Confuturo is expanding alternative assets, including private equity and real estate, as a long-term strategy to diversify its portfolio and improve returns.
International market volatility persisted through April after US tariff announcements, with a gradual recovery emerging in May.
Pension-reform implementation details, including investment-performance rewards and penalties, remain pending regulatory definition.
Latest events from Inversiones La Construcción
- Diversification sets the stage for growth and ambitious bank and annuity profit targets.ILC
Investor Day 2023 - Diversified financial and healthcare growth sets the course for 2030.ILC
Corporate presentation - Q1 profit rose 44.3%, driven by financial subsidiaries despite healthcare margin pressure.ILC
Q1 2023 - FY23 profit rose 24.6%, led by stronger non-operating income and Consalud’s turnaround.ILC
Q4 2023 - Q1 profit rose 69.9%, as financial-subsidiary gains offset Consalud’s GES-related loss.ILC
Q1 2024 - Q2 adjusted profit was offset by weaker markets and Consalud’s Short Law liability.ILC
Q2 2024 - Q3 profit rose 61.6%; 9M24 profit grew 14.4% excluding Consalud’s liability.ILC
Q3 2024 - FY24 profit was Ch$180.614bn before the Short Law liability, down 1.1% YoY.ILC
Q4 2024 - 9M25 profit rose 68.1% to Ch$186,449 million despite Consalud’s liability adjustment.ILC
Q3 2025